US 9713612
Compounds for treatment of cancer
granted A61KA61K31/4375A61K31/444
Quick answer
US patent 9713612 (Compounds for treatment of cancer) held by Curegenix, Inc. expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Curegenix, Inc.
- Grant date
- Tue Jul 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61K, A61K31/4375, A61K31/444, A61K31/472, A61K31/4725